Novel Rift Valley fever vaccine dosed in Phase I human trial
LARISSA consortium reaches milestone Novel Rift Valley fever vaccine dosed in Phase I human trial The first healthy volunteer was dosed...
top of page
Zoeken
info177574
- 1 sep. 2021
- 1 minuten
CSO shift at BunyaVax
Per 31 Aug 2021 Jeroen Kortekaas resigned as CSO of BunyaVax. He has been CSO since September 2017. Jeroen will continue his career as...
163 weergaven0 opmerkingen
Jeroen Kortekaas
- 15 sep. 2020
- 1 minuten
Safety and efficacy of four-segmented Rift Valley fever virus in young sheep, goats and cattle
Please find here our latest paper on the safety and efficacy of our veterinary Rift Valley fever vaccine: https://www.ncbi.nlm.nih.gov/pm...
86 weergaven0 opmerkingen
info177574
- 26 feb. 2020
- 1 minuten
CEO shift at BunyaVax
Per 31 December 2019, Jochem Bossenbroek resigns as CEO of BunyaVax. He has been CEO since September 2017. Carine Punt has been appointed...
566 weergaven0 opmerkingen
info177574
- 10 okt. 2019
- 1 minuten
BunyaVax CEO on stage at Animal AgTech Innovation Summit
On 29-30 September, the first Animal AgTech Innovation Summit was held in Amsterdam. The summit brought together 200 international...
75 weergaven0 opmerkingen
info177574
- 10 jul. 2019
- 4 minuten
BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project
BunyaVax provides technology to develop a human Rift Valley Fever vaccine in a $12.5 million project financed by CEPI BunyaVax is...
221 weergaven0 opmerkingen
info177574
- 17 jan. 2019
- 1 minuten
Jochem Bossenbroek speaker at Investment Trends In Animal Health
On the 17th of January 2019, Jochem will be one of the speakers at the live webinar Investment Trends in Animal Health. The webinar is...
49 weergaven0 opmerkingen
info177574
- 28 sep. 2018
- 1 minuten
BunyaVax featured in 10 Dutch Breakthrough Technologies for 2018
On Thursday 27 September StartupDelta announced their overview of 10 Dutch Breakthrough Technologies for 2018. BunyaVax made it to the...
84 weergaven0 opmerkingen
info177574
- 22 aug. 2018
- 1 minuten
Jochem Bossenbroek invited to speak at the World Agri-Tech Innovation Summit
Jochem Bossenbroek, CEO of BunyaVax, has accepted the invitation to join a panel discussion at the World Agri-Tech Innovation Summit. The...
34 weergaven0 opmerkingen
info177574
- 7 aug. 2018
- 1 minuten
Jeroen Kortekaas to present at the Immuno Valley Annual Conference
Jeroen Kortekaas, CSO of BunyaVax, is invited as session speaker at the Immuno Valley Annual Conference 2018. The event will take place...
65 weergaven0 opmerkingen
info177574
- 13 jun. 2018
- 1 minuten
BunyaVax featured in Wageningen World
The journal Wageningen World has published an article about BunyaVax in the second edition of 2018: "Vaccines within months instead of...
68 weergaven0 opmerkingen
info177574
- 6 apr. 2018
- 1 minuten
Prestigious SME Instrument funding for BunyaVax
BunyaVax receives 50.000 euro from the European Commission (EC). The funding proposal of BunyaVax was selected out of hundreds of...
130 weergaven0 opmerkingen
info177574
- 28 feb. 2018
- 1 minuten
BunyaVax wins innovation award in London
Last week BunyaVax has won the 2018 Innovation Showcase Award at Animal Health Investment Europe. The event, organized by Kisaco...
75 weergaven0 opmerkingen
info177574
- 10 jan. 2018
- 1 minuten
BunyaVax to present at Animal Health Investment Summit
BunyaVax will present at the Animal Health Investment Summit in Londen that will take place on 20-21 Februari 2018. BunyaVax is one of...
73 weergaven0 opmerkingen
info177574
- 10 jan. 2018
- 1 minuten
BunyaVax receives 40k Take-off grant
BunyaVax has been awarded €40k under the NWO Take-off programme. The grant allows BunyaVax to determine the route to market for its swine...
103 weergaven0 opmerkingen
info177574
- 1 sep. 2017
- 1 minuten
Jochem Bossenbroek appointed as CEO
BunyaVax has appointed Jochem Bossenbroek MSc. MBA as CEO of the company. Jochem has extensive experience in the biotech sector, gained...
111 weergaven0 opmerkingen
info177574
- 26 jul. 2017
- 2 minuten
Jeroen Kortekaas and Paul Wichgers Schreur announce vision for BunyaVax
Prof. Jeroen Kortekaas PhD, CSO of BunyaVax, and Paul Wichgers Schreur PhD, COO of the company, share their vision on the future of...
104 weergaven0 opmerkingen
info177574
- 3 jul. 2017
- 1 minuten
Official launch of BunyaVax B.V.
Today, the biotech company BunyaVax B.V. was officially launched. Goal of the company is to commercialize novel proprietary vaccine...
90 weergaven0 opmerkingen
bottom of page